Xcout Intel
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
Subscribe to see Immunitas Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Immunitas Therapeutics, Inc. at a glance
Immunitas Therapeutics, Inc. is a biotechnology company headquartered in United States, founded in 2019. Its most recent funding round raised $29.1M in August 2021. Xcout tracks 4 named people at Immunitas Therapeutics, Inc., including Amanda Wagner (CEO).
Immunitas Therapeutics, Inc. leadership
- Amanda WagnerCEO
- Lynette HerschaChief Operating Officer
- Annalisa D’AndreaChief Scientific Officer
- James WooldridgeChief Medical Officer
Immunitas Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $29.1M | — | |
| Series B | $58M | 1 named | |
| Series A | $65M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Immunitas Therapeutics, Inc. competitors
A few of Immunitas Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, with an additional office in Belgium. The company focuses on discovering and developing novel immuno-oncology therapeutics for cancer treatment.
Mythic Therapeutics, Inc. is a biotechnology research company headquartered in Waltham, Massachusetts. The company is dedicated to developing a proprietary platform to enhance the effectiveness of antibody-drug conjugates and other antibody-based therapeutics.
Boston Immune Technologies and Therapeutics, Inc. (BITT) is a company headquartered in Winchester, Massachusetts, that specializes in the development of cancer treatments and therapeutics.
Get Immunitas Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Immunitas Therapeutics, Inc. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access